Fibrinogen human

• HAEMOCOMPLETTAN-P 1 G IV ENJEKSIYONLUK / INFUZYONLUK COZELTI TOZUkode batang: 8681624980088

Tidak ada catatan makanan tercatat untuk zat aktif ini.

• Aminocaproic acidMODERAT

  Mengonsumsi Aminocaproic acid bersama Fibrinogen human dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Aminocaproic acid is combined with Fibrinogen human.

• (R)-warfarinRINGAN

  Penggunaan bersama (R)-warfarin dapat menurunkan efektivitas Fibrinogen human.

  Tampilan ahli

  The therapeutic efficacy of Fibrinogen human can be decreased when used in combination with (R)-warfarin.

• 4-hydroxycoumarinRINGAN

  Penggunaan bersama 4-hydroxycoumarin dapat menurunkan efektivitas Fibrinogen human.

  Tampilan ahli

  The therapeutic efficacy of Fibrinogen human can be decreased when used in combination with 4-hydroxycoumarin.

• AbciximabRINGAN

  Penggunaan bersama Abciximab dapat menurunkan efektivitas Fibrinogen human.

  Tampilan ahli

  The therapeutic efficacy of Fibrinogen human can be decreased when used in combination with Abciximab.

• AcenocoumarolRINGAN

  Penggunaan bersama Acenocoumarol dapat menurunkan efektivitas Fibrinogen human.

  Tampilan ahli

  The therapeutic efficacy of Fibrinogen human can be decreased when used in combination with Acenocoumarol.

• Alpha-1-proteinase inhibitorRINGAN

  Penggunaan bersama Alpha-1-proteinase inhibitor dapat meningkatkan efektivitas Fibrinogen human.

  Tampilan ahli

  The therapeutic efficacy of Fibrinogen human can be increased when used in combination with Alpha-1-proteinase inhibitor.

• AlteplaseRINGAN

  Penggunaan bersama Alteplase dapat menurunkan efektivitas Fibrinogen human.

  Tampilan ahli

  The therapeutic efficacy of Fibrinogen human can be decreased when used in combination with Alteplase.

• AmediplaseRINGAN

  Penggunaan bersama Amediplase dapat menurunkan efektivitas Fibrinogen human.

  Tampilan ahli

  The therapeutic efficacy of Fibrinogen human can be decreased when used in combination with Amediplase.

• AncrodRINGAN

  Penggunaan bersama Ancrod dapat menurunkan efektivitas Fibrinogen human.

  Tampilan ahli

  The therapeutic efficacy of Fibrinogen human can be decreased when used in combination with Ancrod.

• AnistreplaseRINGAN

  Penggunaan bersama Anistreplase dapat menurunkan efektivitas Fibrinogen human.

  Tampilan ahli

  The therapeutic efficacy of Fibrinogen human can be decreased when used in combination with Anistreplase.